Condition: Advanced Solid Tumor · Sponsor: Barbara Ann Karmanos Cancer Institute
The goal of this clinical trial is to evaluate the safety of Metformin alone and in combination with chemotherapy or immunotherapy in patients with solid tumor cancers. The main questions it aims to answer are: * what are the toxicities of metformin at multiple dose levels * what is the maximum tolerated dose of Metformin in combination with chemotherapy or immunotherapy Participants enrolled will be treated with standard of care chemotherapy and/or immunotherapy in accordance to their disease/stage. In addition, participants will take Metformin alone for 14 days in between the first cycle of chemotherapy and the second cycle of chemotherapy to determine tolerability to the Metformin. Participants will then take Metformin daily in combination with the standard of care chemotherapy and/or Immunotherapy from cycle 2 onwards.
This description comes directly from the study's public registry record.
Wasif Saif, M.D. · (313) 576-8706 · saifw@karmanos.org
Always discuss trial participation with your own doctor first.
| Karmanos Cancer Institute at McLaren Bay Region | Bay City, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Clarkston | Clarkston, Michigan, United States | Recruiting |
| Karmanos Cancer Institute | Detroit, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Flint | Flint, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Greater Lansing | Lansing, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Lapeer Region | Lapeer, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Macomb | Macomb, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center | Mount Pleasant, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Northern Michigan, Petoskey | Petoskey, Michigan, United States | Recruiting |
| Karmanos Cancer Institute at McLaren Port Huron | Port Huron, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07098299